DOXIMITY INC DL-,001 Logo
US26622P1075
A3CS1K
DOCS

DOXIMITY INC DL-,001

Loading quotes...

Forecast

The analysts' average price target is €28.93 (+7.15%). The median is €29.62 (+9.70%).

Buy
  9
Hold
  13
Sell
  2

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Doximity falls after downgrade by Freedom Capital

    Doximity shares dropped 5.6% after Freedom Capital cut its rating from "buy" to "hold" while raising the price target from $24 to $27. The company reported Q1 results above expectations and raised its revenue outlook but lowered its EBITDA forecast to fund increased investments in AI development and computing power. Freedom Capital reduced its mid-point EBITDA estimate for 2027 from $329 million to $319 million and cited a balanced risk-reward profile for the downgrade; competition from Epic and OpenEvidence and tight pharma budgets remain risks, while AI search contracts are showing early positive momentum. » More on de.investing.com


  • Doximity CEO sells 8,505 shares to cover tax withholding after equity vesting

    Doximity CEO Jeffrey Tangney sold 8,505 Class A shares on August 15 to satisfy tax withholding from vested awards, a non-discretionary transaction that reduced his direct stake by roughly 0.3% to 2,531,955 shares (about 1% ownership). The sale does not reflect a market judgment by Tangney and three other insiders had similar withholdings the same day. Company results show slowing top-line growth, margin pressure from rising AI compute costs, and a guidance lull as AI-related revenue recognition is expected later in the year, while the stock has fallen over 60% in the past year. » More on finance.yahoo.com


  • Doximity granted president 150,000 options as he sold small stake to cover taxes

    Doximity president Steven L. Zatz sold 4,482 Class A shares in a non‑discretionary sell‑to‑cover to satisfy tax withholding after RSU vesting and retains 51,864 shares (~$1.29m at $24.80). The company granted Zatz 150,000 options on July 22 with a $20.49 strike that begin vesting in July 2027, tying future pay to stock appreciation. Doximity reported Q2 revenue of $156.6m (7% growth) and raised its full‑year range while AI compute costs lowered gross margin to 87.5% and adjusted EBITDA fell 6% to $74.8m; management says higher‑than‑expected AI usage should drive future revenue recognition. Investors should note the option grant links executive upside to stock performance as AI‑related costs and upcoming AI revenue recognition will affect margins and earnings. » More on finance.yahoo.com


  • Doximity CFO sells shares to cover taxes but keeps $12.1 million stake

    Doximity CFO Matthew Sonefeldt reported a non-discretionary sale of 15,311 Class A shares on August 15 to satisfy tax obligations from equity vesting, leaving him with 486,238 shares valued at about $12.1 million. The filing does not signal a change in his view of the company. Doximity posted TTM revenue of $655.6 million and net income of $167.0 million, but guided to roughly 1% revenue growth for the September quarter as AI-related timing and higher AI compute costs pressured gross margin and adjusted EBITDA; the company also spent $91.6 million on share repurchases. Investors should note the transaction was routine vesting-related withholding and weigh it against the company's mixed near-term growth outlook and solid profitability. » More on finance.yahoo.com


  • Doximity says AI is generating high‑margin searches, shares jump

    Doximity reported fiscal Q1 revenue of $156.6 million, up 7% year‑over‑year, while adjusted EBITDA fell 6% to $74.8 million as the company invests in AI. Management said its AI assistant outperformed peer models in an independent study, driving AI prompt volume up more than 25% quarter‑on‑quarter and AI Scribe users rising tenfold in July. CEO Jeff Tangney stated the company earns more than 10 times the cost per AI search today and expects AI costs to decline over time, signaling strong profit potential and prompting the stock rally. » More on finance.yahoo.com

Historical dividends Dividends

All dividend metrics All metrics
In 2022, DOXIMITY INC DL-,001 has already paid €0.54 in dividends. The last payout was in July 2022.

Financials

In the last quarter, DOXIMITY INC DL-,001 had revenue of €154.09m and net profit of €30.66m
(EUR) September 2026
YoY
Revenue 154.09m 7.30%
Gross profit 131.71m 1.62%
Net profit 30.66m 42.02%
EBITDA 48.27m 25.86%

Fundamentals

Metric Value
Market capitalization
€5.05bn
Number of shares
178.24m
52-week high/low
€47.25 - €15.63
Dividends No
Beta
1.29
P/E ratio
41.48
PEG ratio
-0.94
P/B ratio
5.99
P/S ratio
8.38

Company profile

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Name
DOXIMITY INC DL-,001
CEO
Jeffrey A. Tangney
Headquarters San Francisco, ca
USA
Website
Sector
Health Care
Industry
Health Care Technology
IPO
02/01/2008
Employees 880

Ticker symbols

Exchange Symbol
NYSE
DOCS
🍪

Parqet  uses cookies. Learn more